Modulation of the oncogenic potential of various anticancer modalities.
Hall
E J
EJ
Department of Radiation Oncology, College of Physicians and Surgeons, Columbia University, New York, N.Y.
Hei
T K
TK
Miller
R C
RC
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002460:Cell Line / Q000187:drug effects / Q000528:radiation effects; D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000528:radiation effects; D003131:Combined Modality Therapy / Q000009:adverse effects; D006801:Humans; D009369:Neoplasms / Q000517:prevention & control*; D009374:Neoplasms, Experimental / Q000517:prevention & control; D009381:Neoplasms, Radiation-Induced / Q000517:prevention & control; D011878:Radiotherapy / Q000009:adverse effects*
D000970:Antineoplastic Agents